211 related articles for article (PubMed ID: 19661309)
21. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Adhami VM; Afaq F; Ahmad N
Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
[TBL] [Abstract][Full Text] [Related]
23. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM
Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348
[TBL] [Abstract][Full Text] [Related]
24. Effects of resveratrol and other wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells.
Ferruelo A; Romero I; Cabrera PM; Arance I; Andrés G; Angulo JC
Actas Urol Esp; 2014; 38(6):397-404. PubMed ID: 24726691
[TBL] [Abstract][Full Text] [Related]
25. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells.
Liu S; Yamauchi H
Oncol Rep; 2010 Jan; 23(1):165-70. PubMed ID: 19956877
[TBL] [Abstract][Full Text] [Related]
26. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
27. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
Sareen D; van Ginkel PR; Takach JC; Mohiuddin A; Darjatmoko SR; Albert DM; Polans AS
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3708-16. PubMed ID: 16936077
[TBL] [Abstract][Full Text] [Related]
30. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
[TBL] [Abstract][Full Text] [Related]
32. Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells.
Gao S; Liu GZ; Wang Z
Prostate; 2004 May; 59(2):214-25. PubMed ID: 15042621
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N
Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
Golkar L; Ding XZ; Ujiki MB; Salabat MR; Kelly DL; Scholtens D; Fought AJ; Bentrem DJ; Talamonti MS; Bell RH; Adrian TE
J Surg Res; 2007 Apr; 138(2):163-9. PubMed ID: 17257620
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
Yuan H; Pan Y; Young CY
Cancer Lett; 2004 Sep; 213(2):155-63. PubMed ID: 15327830
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells.
Harada N; Murata Y; Yamaji R; Miura T; Inui H; Nakano Y
J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):556-60. PubMed ID: 18202547
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
[TBL] [Abstract][Full Text] [Related]
38. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
[TBL] [Abstract][Full Text] [Related]
40. Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cells.
Hu Z; Zhang D; Wang D; Sun B; Safoor A; Young CY; Lou H; Yuan H
Pharm Biol; 2016; 54(2):364-74. PubMed ID: 26017567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
